Showing results (3011-3020 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|December 26, 2007
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemiaMichael Steinberg
Clinical Therapeutics|December 26, 2007
Tipranavir: the first nonpeptidic protease inhibitor for the treatment of protease resistanceBeatriz Luna, Mary U Townsend
Clinical Therapeutics|December 26, 2007
Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemiaSang Hak Lee, Namsik Chung, Jun Kwan, et al.
Clinical Therapeutics|December 26, 2007
Community-phenotype-methicillin-resistant Staphylococcus aureus infections: a retrospective chart review of outcomes after treatment with daptomycinDavid E Katz, William J Martone
Clinical Therapeutics|April 19, 2014
Evaluation of the efficacy and tolerability of fixed-dose combination therapy of azilsartan and amlodipine besylate in Japanese patients with grade I to II essential hypertensionHiromi Rakugi, Emi Nakata, Emma Sasaki, et al.
Clinical Therapeutics|May 10, 2014
Evaluating the psychometric properties of the CAHPS Patient-centered Medical Home surveyRon D Hays, Laura J Berman, Michael H Kanter, et al.
Clinical Therapeutics|May 10, 2014
The STAR Study: a real-world, international, observational study of the safety and tolerability of, and adherence to, serum-free subcutaneous interferon β-1a in patients with relapsing multiple sclerosisRaymond Hupperts, Lizette Ghazi-Visser, Ana Martins Silva, et al.
Clinical Therapeutics|May 13, 2014
Three-year cost-effectiveness model for non-animal stabilized hyaluronic acid and dextranomer copolymer compared with sacral nerve stimulation after conservative therapy for the management of fecal incontinenceMitchell A Bernstein, Christopher H Purdy, Alison Becker, et al.
Clinical Therapeutics|May 13, 2014
Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndromeDavid A Andrae, Paul S Covington, Donald L Patrick
Clinical Therapeutics|May 13, 2014
Correspondence between the RAND-Negative Impact of Asthma on Quality of Life item bank and the Marks Asthma Quality of Life QuestionnaireMaria Orlando Edelen, Brian D Stucky, Cathy Sherbourne, et al.
Pageof 680